Editorial: vedolizumab in inflammatory bowel diseases-less is more? Authors' reply. Danese S, Subramaniam K, Van Zyl J, Adsul S, et al. Aliment Pharmacol Ther 2021;53:445-446.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Danese S, Subramaniam K, Van Zyl J, Adsul S, et al. Editorial: vedolizumab in inflammatory bowel diseases-less is more? Authors' reply. Aliment Pharmacol Ther 2021;53:445-446.
PMID: 33428255